Use your antibodies-online credentials, if available.
No Products on your Comparison List.
Your basket is empty.
Find out more
Show all species
Show all synonyms
Select your species and application
anti-Human CPT2 Antibodies:
anti-Mouse (Murine) CPT2 Antibodies:
anti-Rat (Rattus) CPT2 Antibodies:
Go to our pre-filtered search.
Human Polyclonal CPT2 Primary Antibody for EIA, WB - ABIN357771
Deschauer, Wieser, Schröder, Zierz: A novel nonsense mutation (515del4) in muscle carnitine palmitoyltransferase II deficiency. in Molecular genetics and metabolism 2002
Show all 5 references for ABIN357771
Human Polyclonal CPT2 Primary Antibody for WB - ABIN1881226
Lan, Fu, Liu, Huang, Chang, Liu, Peng, Chen: High frequency of ETFDH c.250G>A mutation in Taiwanese patients with late-onset lipid storage myopathy. in Clinical genetics 2010
Show all 5 references for ABIN1881226
Human Polyclonal CPT2 Primary Antibody for EIA, WB - ABIN357770
Haap, Thamer, Machann, Tschritter, Löblein, Kellerer, Schick, Jacob, Häring, Stumvoll: Metabolic characterization of a woman homozygous for the Ser113Leu missense mutation in carnitine palmitoyl transferase II. in The Journal of clinical endocrinology and metabolism 2002
Show all 5 references for ABIN357770
Human Polyclonal CPT2 Primary Antibody for ELISA, WB - ABIN4300344
Isackson, Bennett, Lichter-Konecki, Willis, Nyhan, Sutton, Tein, Vladutiu: CPT2 gene mutations resulting in lethal neonatal or severe infantile carnitine palmitoyltransferase II deficiency. in Molecular genetics and metabolism 2008
The clinical presentation of patients with muscle carnitine palmitoyltransferase II deficiency is discussed in this review in line with enzymatic features. The thermolability of the mutant enzyme might explain why symptoms in muscle CPT II deficiency mainly occur during prolonged exercise, infections and exposure to cold. [review]
Variations in AMPD1 (show AMPD1 Antibodies), CPT2, and PGYM genes are not associated with the onset, susceptibility, or severity of chronic fatigue syndrome.
CPT2 is active inside the mitochondrial matrix to recover acyl-CoA (show GNPAT Antibodies) from a process generally known as the carnitine shuttle. This protein is expressed in a constitutive way in all cells and tissues.
CPT II deficiency induces an energy crisis of the fatty acid metabolic pathway.
The rs2229291 and rs1799821 variants in CPT II gene might be one of the predisposing factors of acute encephalitis.
The F352C CPT2 variant might be a genetic risk factor for sudden unexpected death in infancy
The data indicate that within the muscle form of CPT II deficiency, the various genotypes have only marginal influence on the clinical and biochemical phenotype.
The homozygous genotype (AA) of CPT2 variant V368I had significantly less blood carnitine in acute myocardial infarction patients.
Allelic and phenotypic heterogeneity in 49 Italian patients with the muscle form of CPT-II deficiency
CPT2 and CACT (show SLC25A20 Antibodies) are crucial for mitochondrial acylcarnitine formation and export to the extracellular fluids in mitochondrial fatty acid beta-oxidation disorders.
Mice acclimatized to thermoneutrality revealed that Cpt2A-null interscapular brown adipose tissue failed to induce the expression of thermogenic genes such as Ucp1 (show UCP1 Antibodies) and Pgc1a (show PPARGC1A Antibodies).
Consistent with the known requirement for CPT2 in fatty acid oxidation, macrophages lacking CPT2 were unable to achieve b-oxidation of fatty acids yet still seemed to fully polarize toward an M2 state after stimulation with IL-4 (show IL4 Antibodies) in vitro and in vivo.
Cpt2 transcripts decrease following fertilization to undetectable levels and are present again later at the morula stage
It was conclude that suppression of CPT (show DHDDS Antibodies) activity by positive energy balance appears to be specific for the liver in mid-lactating dairy cows.
The protein encoded by this gene is a nuclear protein which is transported to the mitochondrial inner membrane. Together with carnitine palmitoyltransferase I, the encoded protein oxidizes long-chain fatty acids in the mitochondria. Defects in this gene are associated with mitochondrial long-chain fatty-acid (LCFA) oxidation disorders.
carnitine O-palmitoyltransferase 2, mitochondrial
, carnitine palmitoyltransferase II
, carnitine palmitoyltransferase 2
, carnitine O-palmitoyltransferase
, carnitine O-palmitoyltransferase 2, mitochondrial-like
, CPT II
, mitochondrial carnitine palmitoyltransferase II